U.S., March 19 -- ClinicalTrials.gov registry received information related to the study (NCT07479784) titled 'Octreotide Microspheres for Preventing Pancreatic Fistula' on March 05.
Brief Summary: This study is a randomized, double-blind, placebo-controlled, multicenter phase III clinical trial designed to evaluate the efficacy and safety of octreotide microspheres in preventing pancreatic fistula after distal pancreatectomy.
Study Start Date: April 01
Study Type: INTERVENTIONAL
Condition:
Pancreatic Fistula
Intervention:
DRUG: Octreotide Microspheres
Octreotide Microspheres: 30mg, intramuscular injection, administered 7 days before surgery
DRUG: Placebo
Control group: Placebo (normal saline), administered 7 days before surgery.
...